TELO — Telomir Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $111.04m
- $107.76m
Annual cashflow statement for Telomir Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.138 | -0.854 | -13.1 |
| Non-Cash Items | — | — | 9.1 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.019 | 0.385 | 0.114 |
| Change in Prepaid Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Cash from Operating Activities | -0.119 | -0.469 | -3.86 |
| Financing Cash Flow Items | 0.119 | 0.47 | -0.31 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.119 | 0.47 | 3.86 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 0.001 | -0 |